Finance

Lists
Why is KNSA up 6,25%?
Dive Deeper
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
93,86 $
+6,25%
(+5,52) 1D
95,00 $
+1,21% (+1,14)
After hours
Closed: 6 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KNSA...
Open
88,92 $
High
94,48 $
Low
88,41 $
Mkt. cap
7,37 մլրդ
Avg. vol.
830,89 հզր
Volume
636,35 հզր
P/E ratio
71,64
52-wk high
98,48 $
52-wk low
37,02 $
EPS
1,31 $
Beta
0,07
Shares outstanding
48,84 մլն
No. of employees
366
Open
88,92 $
High
94,48 $
Low
88,41 $
Mkt. cap
7,37 մլրդ
Avg. vol.
830,89 հզր
Volume
636,35 հզր
P/E ratio
71,64
52-wk high
98,48 $
52-wk low
37,02 $
EPS
1,31 $
Beta
0,07
Shares outstanding
48,84 մլն
No. of employees
366
News stories
From web sources and news partners
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersԼոնդոն, Անգլիա, Միացյալ Թագավորություն
SectorHealth Care
Industry-
Analyst ratings
Based on 5 analysts giving stock ratings to KNSA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KNSA in the last 3 months.
Highest
Current 93,86 $
122,00 $ (+29,98%)
Average
106,20 $ (+13,15%)
Lowest
98,00 $ (+4,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Reiterated
122,00 $
+30%
10/30/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
98,00 $
+4,4%
10/28/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
110,00 $
+17,2%
10/28/2026
Paul Choi
Goldman Sachs
Buy
Reiterated
101,00 $
+7,6%
10/27/2026
Geoff Meacham
Citi
Buy
Maintained
100,00 $
+6,5%
10/15/2026
David Nierengarten
Wedbush
Buy
Reiterated
99,00 $
+5,5%
07/28/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
87,00 $
-7,3%
07/29/2026
Nicholas Lorusso
TD Cowen
Buy
Reiterated
95,00 $
+1,2%
07/28/2026
Roger Song
Jefferies
Buy
Maintained
71,00 $
-24,4%
04/28/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
53,00 $
-43,5%
04/14/2026
Last report
27 հոկ, 2026 թ.
Fiscal period
Q3 2026
0,56 $ / 0,31 $
+79,20%beat
Revenue / Est. (USD)
285,97 մլն / 260,61 մլն
+9,73%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
202,13 մլն
214,27 մլն
243,60 մլն
285,97 մլն
Cost of goods sold
90,98 մլն
96,37 մլն
111,64 մլն
133,59 մլն
Cost of revenue
90,98 մլն
96,37 մլն
111,64 մլն
133,59 մլն
Research and development expenses
34,61 մլն
27,48 մլն
40,90 մլն
32,79 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,78 մլն
61,15 մլն
63,87 մլն
65,36 մլն
Operating expense
91,38 մլն
88,63 մլն
104,76 մլն
98,15 մլն
Total operating expenses
182,36 մլն
185,00 մլն
216,41 մլն
231,73 մլն
Operating income
19,77 մլն
29,27 մլն
27,19 մլն
54,24 մլն
Other non operating income
3,50 մլն
3,41 մլն
3,95 մլն
-169,00 հզր
EBT including unusual items
23,27 մլն
32,68 մլն
31,14 մլն
59,06 մլն
EBT excluding unusual items
23,27 մլն
32,68 մլն
31,14 մլն
59,06 մլն
Income tax expense
9,07 մլն
10,09 մլն
5,71 մլն
11,71 մլն
Effective tax rate
38,98%
30,87%
18,34%
19,83%
Other operating expenses
-
-
-
-
Net income
14,20 մլն
22,59 մլն
25,43 մլն
47,34 մլն
Net profit margin
7,02%
10,54%
10,44%
16,56%
Earnings per share
0,17
0,27
0,30
0,56
Interest and investment income
-
-
-
4,99 մլն
Interest expense
-
-
-
-
Net interest expenses
-
-
-
4,99 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
20,24 մլն
29,74 մլն
27,67 մլն
54,73 մլն
Gain or loss from assets sale
-53,00 հզր
-54,00 հզր
22,00 հզր
8,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps